Eurobio Scientific Société anonyme (EPA: ALERS)

Market Cap	247.58M
Revenue (ttm)	130.65M
Net Income (ttm)	4.84M
Shares Out	10.04M
EPS (ttm)	0.43
PE Ratio	57.33
Forward PE	25.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,379
Open	24.60
Previous Close	24.60
Day's Range	24.60 - 24.70
52-Week Range	12.20 - 24.75
Beta	-0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 24, 2024

About ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the ev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 300
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2023, Lumibird's revenue was 206.55 million, an increase of 6.31% compared to the previous year's 194.29 million. Earnings were 7.13 million, a decrease of -37.23%.